About
Adaptimmune Therapeutics PLC develops engineered T-cell therapies for cancer treatment with a focus on using cell therapy to target and kill cancer cells.
Explore Adaptimmune Therapeutics PLC's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.